Clinical observation of esmolol for the treatment of acute myocardial infarction with sympathetic storm
10.3760/cma.j.issn.1008-6315.2015.12.009
- VernacularTitle:艾司洛尔治疗急性心肌梗死后交感风暴的临床观察
- Author:
Yao LI
;
Wanlin CHEN
- Publication Type:Journal Article
- Keywords:
Esmolol;
Acute myocardial infarction;
Sympathetic storm;
Cardioversion;
Electric defibrillation
- From:
Clinical Medicine of China
2015;31(12):1083-1086
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the efficacy and safety of esmolol for the treatment of acute myocardial infarction patients with sympathetic storm.Methods Sixty acute myocardial infarction patients who suffered from sympathetic storm during the hospitalization from January 2013 to January 2015 in the People's Hospital of Baoji City.The patients were randomly divided into two groups : esmolol group(patients were treated with cardioversion or electric defibrillation and esmolol, n =30) and control group (patients were treated with cardioversion or electric defibrillation and amiodarone, n =30).Results The effective rate of esmolol group was 93.33％ (28/30), of control group was 70.00％ (21/30), and the difference was significant (x2 =5.455, P =0.020).The success rate of esmolol group which terminated sympathetic storm was significantly higher than control group (28％ vs.20％, P =0.020).Recurrence of ventricular tachycardia or ventricular fibrillation after esmolol treatment was significantly lower, the corresponding were less (3.30± 2.76 vs.6.83 ± 4.58, P =0.001).Esmolol group was no occurrence of hypotension that could not be corrected or severe slow arrhythmia.NTproBNP level between the two groups was not statistically significant observation (P ＞ 0.05).Conclusion Esmolol treatment of sympathetic storm is better efficacy, safety and be worthy of clinical application.
